ARCHIVES

Sharp To Direct New Institute For Brain Research At MIT.

This article is from The Cancer Letter archive.

Vol. 26 No. 09 | March 3, 2000

Download PDF Visit The Full Archive

Related Articles

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

Liver Transplants Extend Survival In Early-Stage Cancer

January 27, 2006